Jeffrey L. Ives Acumen Pharmaceuticals, Inc. (ABOS) insider trading activity

ABOS Quotes by TradingView

Jeffrey L. Ives is Director of Acumen Pharmaceuticals, Inc.. Currently has a direct ownership of 12,800 shares of ABOS, which is worth approximately $15,360. The most recent transaction as insider was on Jun 04, 2025, when has been sold 12,800 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.8K
Infinity% 3M change
Infinity% 12M change
Total Value Held $15,360

Jeffrey L. Ives Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 04 2025
BUY
Grant, award, or other acquisition
-
12,800 Added 50.0%
12,800 Common Stock
Aug 17 2023
SELL
Open market or private sale
$275,604 $6.57 p/Share
41,949 Reduced 100.0%
0 Common Stock
Aug 17 2023
BUY
Exercise of conversion of derivative security
$40,271 $0.96 p/Share
41,949 Added 93.74%
2,800 Common Stock

Also insider at

CARA
Cara Therapeutics, Inc. Healthcare
JLI

Jeffrey L. Ives

Director
Stamford, CT

Track Institutional and Insider Activities on ABOS

Follow Acumen Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABOS shares.

Notify only if

Insider Trading

Get notified when an Acumen Pharmaceuticals, Inc. insider buys or sells ABOS shares.

Notify only if

News

Receive news related to Acumen Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ABOS